, , 2015.
Epigenetic modifications in cancer, Clin. Genet, vol.81, issue.4, pp.303-311, 2012. ,
Les acides nucléiques du plasma sanguin chez l'homme, C. R. Seances Soc. Biol. Fil, vol.142, issue.3-4, pp.241-243, 1948. ,
Detection of nuclear antigens (DNA) in normal and pathologic human fluids by quantitative complement fixation, Arthritis Rheum, vol.11, issue.3, pp.407-417, 1968. ,
Detection of circulating DNA by counterimmunoelectrophoresis (CIE), Arthritis Rheum, vol.16, issue.1, pp.52-58, 1973. ,
Cell-free nucleic acids in plasma, serum and urine: a new tool in molecular diagnosis, Ann. Clin. Biochem, vol.40, issue.2, pp.122-130, 2003. ,
Circulating nucleic acids (CNAs) and cancer -a survey, Biochim. Biophys. Acta BBA Rev. Cancer, vol.1775, issue.1, pp.181-232, 2007. ,
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease, Nat. Commun, vol.9, issue.1, p.5068, 2018. ,
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system, Cancer Res, vol.35, issue.9, pp.2375-2382, 1975. ,
Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen, Proc. Natl Acad. Sci. USA, vol.69, issue.7, pp.1685-1689, 1972. ,
Circulating tumor DNA as biomarkers for cancer detection, Genomics Proteomics Bioinformatics, vol.15, issue.2, pp.59-72, 2017. ,
,
Presence of fetal DNA in maternal plasma and serum, Lancet, vol.350, issue.9076, pp.485-487, 1997. ,
Elevated cell-free plasma DNA level as an independent predictor of mortality in patients with severe traumatic brain injury, J. Neurotrauma, vol.31, pp.1639-1646, 2014. ,
Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state, Arterioscler. Thromb. Vasc. Biol, vol.33, issue.8, pp.2032-2040, 2013. ,
Cell-free DNA release under psychosocial and physical stress conditions, Transl. Psychiatry, vol.8, issue.1, p.236, 2018. ,
Analytical and clinical validation of a digital sequencing panel for quantitative, highly accurate evaluation of cell-free circulating tumor DNA, PLoS ONE, vol.10, issue.10, p.140712, 2015. ,
The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients, Int. J. Mol. Sci, vol.14, issue.9, pp.18925-18958, 2013. ,
Characterization of the release of DNA by a human leukemia-cell line hl-60, Int. J. Oncol, vol.4, issue.2, pp.417-421, 1994. ,
About the possible origin and mechanism of circulating DNA apoptosis and active DNA release, Clin. Chim. Acta Int. J. Clin. Chem, vol.313, issue.1-2, pp.139-142, 2001. ,
Characterization of the cell-free DNA released by cultured cancer cells, Biochim. Biophys. Acta BBA Mol. Cell Res, vol.1863, issue.1, pp.157-165, 2016. ,
DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells, Cancer Res, vol.61, issue.4, pp.1659-1665, 2001. ,
Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR, Clin. Chem, vol.51, issue.8, pp.1544-1546, 2005. ,
Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin, Cell, vol.164, issue.1-2, pp.57-68, 2016. ,
Circulating nucleic acids in blood of healthy male and female donors, Clin. Chem, vol.51, issue.7, pp.1317-1319, 2005. ,
Keeping tabs on tumor DNA, Science, vol.327, issue.5969, pp.1074-1074, 2010. ,
Liquid biopsies come of age: towards implementation of circulating tumour DNA, Nat. Rev. Cancer, vol.17, p.223, 2017. ,
Detection and quantification of mutations in the plasma of patients with colorectal tumors, Proc. Natl Acad. Sci. USA, vol.102, issue.45, pp.16368-16373, 2005. ,
Detection of circulating tumor DNA in early-and late-stage human malignancies, Sci. Transl. Med, vol.6, issue.224, pp.224-248, 2014. ,
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma, Cancer Biol. Ther, vol.5, issue.10, pp.1369-1374, 2006. ,
The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics, Trends Genet, vol.32, issue.6, pp.360-371, 2016. ,
Fragment length of circulating tumor DNA, PLoS Genet, vol.12, issue.7, p.1006162, 2016. ,
Genome-wide cell-free DNA fragmentation in patients with cancer, Nature, vol.570, issue.7761, pp.385-389, 2019. ,
Is it a new era of mutation testing for non-small cell lung cancer?, Ann. Transl. Med, vol.5, issue.3, p.46, 2017. ,
Tumor fraction in cell-free DNA as a biomarker in prostate cancer, JCI Insight, 2018. ,
Circulating tumor DNA detection: a potential tool for colorectal cancer management (Review), Oncol. Lett, 2018. ,
Increased plasma circulating cell-free DNA could be a potential marker for oral cancer, Int. J. Mol. Sci, vol.19, issue.11, p.3303, 2018. ,
KRAS mutations in ctDNA: a promising new biomarker in advanced pancreatic cancer, Ann. Oncol, vol.29, issue.12, pp.2280-2282, 2018. ,
Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers, Oncogene, 2019. ,
Application of cell-free DNA analysis to cancer treatment, N. Engl. J. Med, vol.379, issue.18, pp.1754-1765, 2018. ,
, The epigenomics of cancer. Cell, vol.128, issue.4, pp.683-692, 2007.
Epigenetic biomarkers in cell-free DNA and applications in liquid biopsy, Genes, vol.10, issue.1, p.32, 2019. ,
Identification of tissue-specific cell death using methylation patterns of circulating DNA, Proc. Natl Acad. Sci. USA, vol.113, issue.13, pp.1826-1834, 2016. ,
Sensitive tumour detection and classification using plasma cell-free DNA methylomes, Nature, vol.563, issue.7732, pp.579-583, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01974928
Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments, Proc. Natl Acad. Sci. USA, vol.112, issue.40, pp.5503-5512, 2015. ,
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease, Nat. Commun, vol.9, issue.1, p.5068, 2018. ,
The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer, Pathol. Oncol. Res, vol.17, issue.3, pp.503-509, 2011. ,
From discovery to the clinic: the novel DNA methylation biomarker m SEPT9 for the detection of colorectal cancer in blood, Epigenomics, vol.2, issue.4, pp.575-585, 2010. ,
Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection, World J. Gastrointest. Oncol, vol.10, issue.1, pp.15-22, 2018. ,
Epi proColon R : use of a non-invasive SEPT9 gene methylation blood test for colorectal cancer screening: a national laboratory experience, J. Clin. Epigenetics, 2018. ,
Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma, Clin. Chem, vol.60, issue.9, pp.1183-1191, 2014. ,
Cell-free circulating methylated SEPT9 for noninvasive diagnosis and monitoring of colorectal cancer, Dis. Markers, pp.1-11, 2018. ,
The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer, Biomark. Med, vol.12, issue.9, pp.961-973, 2018. ,
Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma, Nat. Mater, vol.16, p.1155, 2017. ,
The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer, Genome Med, vol.9, issue.1, 2017. ,
,
Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker, Cancer Genet, pp.159-168, 2018. ,
Identifying aggressive prostate cancer foci using a DNA methylation classifier, Genome Biol, 2017. ,
Chromatin structure: a repeating unit of histones and DNA, Science, vol.184, issue.4139, pp.868-871, 1974. ,
Nucleosomes, linker DNA, and linker histone form a unique structural motif that directs the higher-order folding and compaction of chromatin, Proc. Natl Acad. Sci. USA, vol.95, issue.24, pp.14173-14178, 1998. ,
Crystal structure of the nucleosome core particle at 2.8Å resolution, Nature, vol.389, issue.6648, pp.251-260, 1997. ,
Structure of the chromatosome, a chromatin particle containing 160 base pairs of DNA and all the histones, Biochemistry, vol.17, issue.25, pp.5524-5531, 1978. ,
Regulation of chromatin by histone modifications, Cell Res, vol.21, issue.3, pp.381-395, 2011. ,
Regulation of nucleosome dynamics by histone modifications, Nat. Struct. Amp Mol. Biol, vol.20, p.259, 2013. ,
Elongation by RNA polymerase II: the short and long of it, Genes Dev, vol.18, issue.20, pp.2437-2468, 2004. ,
Histone core modifications regulating nucleosome structure and dynamics, Nat. Rev. Mol. Cell Biol, vol.15, issue.11, pp.703-708, 2014. ,
The language of covalent histone modifications, Nature, vol.403, issue.6765, pp.41-45, 2000. ,
A packing mechanism for nucleosome organization reconstituted across a eukaryotic genome, Science, vol.332, issue.6032, pp.977-980, 2011. ,
Chromatin dynamics coupled to DNA repair, Epigenetics, vol.4, issue.1, pp.31-42, 2009. ,
Histone modifications and the maintenance of telomere integrity, Cells, vol.8, issue.2, p.199, 2019. ,
Epigenetic modifications and human disease, Nat. Biotechnol, vol.28, issue.10, pp.1057-1068, 2010. ,
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer, Nat. Genet, vol.37, issue.4, p.391, 2005. ,
,
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer, Cancer Res, vol.62, issue.24, pp.7213-7218, 2002. ,
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas, Hepatol. Res, vol.37, issue.11, pp.974-983, 2007. ,
5-Aza-2 -deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation, Oncogene, vol.26, issue.1, pp.77-90, 2007. ,
H3K9 trimethylation silences Fas expression to confer colon carcinoma immune escape and 5-fluorouracil chemoresistance, J. Immunol, vol.195, issue.4, pp.1868-1882, 2015. ,
Phosphorylation of histone H4T80 triggers DNA damage checkpoint recovery, Mol. Cell, vol.72, issue.4, 2018. ,
CDK1-mediated phosphorylation at H2B serine 6 is required for mitotic chromosome segregation, J. Cell Biol, vol.218, issue.4, pp.1164-1181, 2019. ,
JMJD6 regulates histone H2A. X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity, Oncogene, vol.38, issue.7, pp.980-997, 2019. ,
ACK1/TNK2 regulates histone H4 Tyr88-phosphorylation and AR gene expression in castration-resistant prostate cancer, Cancer Cell, vol.31, issue.6, 2017. ,
PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis, Cell, vol.150, issue.4, pp.685-696, 2012. ,
HDAC and HDAC inhibitor: from cancer to cardiovascular diseases, Chonnam Med. J, vol.52, issue.1, pp.1-11, 2016. ,
Enhancing the anticancer efficacy of immunotherapy through combination with histone modification inhibitors, Genes, 2018. ,
Real-time liquid biopsies become a reality in cancer treatment, Ann. Transl. Med, 2015. ,
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD, Nature, vol.391, issue.6662, pp.43-50, 1998. ,
Novel serum nucleosomics biomarkers for the detection of colorectal cancer, Anticancer Res, vol.34, issue.5, pp.2357-2362, 2014. ,
Extracellular histones are major mediators of death in sepsis, Nat. Med, vol.15, issue.11, pp.1318-1321, 2009. ,
Extracellular histones in tissue injury and inflammation, J. Mol. Med. Berl. Ger, vol.92, issue.5, pp.465-472, 2014. ,
Release and activity of histone in diseases, Cell Death Dis, vol.5, issue.8, p.1370, 2014. ,
Plasma nucleosome levels in node-negative breast cancer patients, Breast Cancer, vol.6, issue.4, pp.361-364, 1999. ,
Circulating nucleosomes in serum, Ann. NY Acad. Sci, vol.945, issue.1, pp.93-102, 2006. ,
Extracellular histone release in response to traumatic injury: implications for a compensatory role of activated protein C, J. Trauma Acute Care Surg, vol.73, issue.6, pp.1389-1394, 2012. ,
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer, Clin. Epigenetics, vol.9, issue.53, 2017. ,
For the Danish Collaborative Group on EA. Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer. Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer, Oncotarget, vol.9, issue.12, pp.10247-10258, 2017. ,
Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.10, pp.5981-5987, 2004. ,
Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing selective internal radiation therapy, BMC Cancer, vol.12, p.5, 2012. ,
Prediction of response to neoadjuvant chemotherapy in breast cancer patients by circulating apoptotic biomarkers nucleosomes, DNAse, cytokeratin-18 fragments and survivin, Cancer Lett, vol.336, issue.1, pp.140-148, 2013. ,
Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide, Drug Discov. Today, vol.20, issue.7, pp.899-905, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01392441
Is glioblastoma an epigenetic malignancy, Cancers, vol.5, issue.4, pp.1120-1139, 2013. ,
, Histone H3 phosphorylation in GBM: a new rational to guide the use of kinase inhibitors in anti-GBM therapy, vol.5, pp.12-22, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-01820696
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Nature, vol.447, issue.7146, pp.799-816, 2007. ,
The functions and unique features of long intergenic non-coding RNA, Nat. Rev. Mol. Cell Biol, vol.19, issue.3, pp.143-157, 2018. ,
Circular RNAs in cancer, Mol. Ther. Nucleic Acids, vol.16, pp.118-129, 2019. ,
Non-coding RNAs in human disease, Nat. Rev. Genet, vol.12, issue.12, pp.861-874, 2011. ,
Circulating RNA molecules as biomarkers in liver disease, Int. J. Mol. Sci, vol.15, issue.10, pp.17644-17666, 2014. ,
Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma, RNA Biol, vol.9, issue.8, pp.1066-1075, 2012. ,
A comprehensive profile of circulating RNAs in human serum, RNA Biol, vol.15, issue.2, pp.242-250, 2018. ,
Circulating microRNAs: promising breast cancer Biomarkers, Breast Cancer Res. BCR, vol.13, issue.1, p.403, 2011. ,
Long non-coding RNAs in multiple myeloma, Non-Coding RNA, vol.5, issue.1, 2019. ,
Detecting and characterizing circular RNAs, Nat. Biotechnol, vol.32, issue.5, pp.453-461, 2014. ,
The plasma lncRNA acting as fingerprint in non-small-cell lung cancer, Tumour Biol. J. Int. Soc. Oncodevelopmental Biol. Med, vol.37, issue.3, pp.3497-3504, 2016. ,
MicroRNAs as biomarkers in colorectal cancer, Cancers, vol.9, issue.9, p.124, 2017. ,
Advances in circular RNAs and their roles in breast cancer, J. Exp. Clin. Cancer Res. CR, vol.37, issue.1, p.206, 2018. ,
A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer, Life Sci, vol.151, pp.235-242, 2016. ,
Evaluation of circulatory RNA-based biomarker panel in hepatocellular carcinoma, Mol. Diagn. Ther, vol.20, issue.3, pp.265-277, 2016. ,
A panel of serum noncoding RNAs for the diagnosis and monitoring of response to therapy in patients with breast cancer, Med. Sci. Monit. Int. Med. J. Exp. Clin. Res, vol.24, pp.2476-2488, 2018. ,
miR-370-3p is a therapeutic tool in anti-glioblastoma therapy but is not an intratumoral or cell-free circulating biomarker, Mol. Ther. -Nucleic Acids, vol.13, pp.642-650, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01982015
Epigenetic gene silencing in cancer -a mechanism for early oncogenic pathway addiction?, Nat. Rev. Cancer, vol.6, issue.2, pp.107-116, 2006. ,
Histone onco-modifications, Oncogene, vol.30, issue.31, pp.3391-3403, 2011. ,
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection, BMC Med, 2018. ,
Noncoding RNAs in extracellular fluids as cancer biomarkers: The new frontier of liquid biopsies, Cancers, vol.11, issue.8, p.1170, 2019. ,
Circulating nucleosomes and nucleosome modifications as biomarkers in cancer, Cancers, vol.9, issue.1, p.5, 2017. ,
Early epigenetic markers for precision medicine, Cancer Epigenetics for Precision Medicine. Verma M, pp.3-17, 2018. ,
Cancer biomarkers: written in blood, Nature, vol.511, issue.7511, pp.524-526, 2014. ,